Paras Biopharmaceuticals Finland Oy is a Finnish biologics CDMO based in Oulu, Finland, specializing in contract development and microbial biologics manufacturing. The company has a fully owned 25,000 sq ft state-of-the-art biologics production plant. Major activities include Biologics CDMO services and biologics technology development, including the proprietary Diabrid Platform. Recognized as one of the fastest-growing companies in Nordic biotechnology. Currently investing in expansion of its Oulu production site.
Microbial biologics contract manufacturing. Recombinant protein production. Proprietary Diabrid Platform technology. Focus on affordable healthcare through biologics manufacturing.
1 site worldwide
No reviews available yet.
No documents available.